Condition (MeSH)
Granulomatous Mastitis
ClinicalTrials.gov lists 17 trials for Granulomatous Mastitis or a narrower condition beneath it. Istanbul Training and Research Hospital has the most among industry and government lead sponsors, with 2.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
17 of the 17 trials are tagged with Granulomatous Mastitis itself; the rest are tagged with a narrower condition beneath it.
When did Granulomatous Mastitis trials start? (8)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 4
- Not applicable
- Observational
Top of scale: 4
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 3 |
| 2025 | 1 |
| 2024 | 4 |
| 2021 | 1 |
| 2020 | 2 |
| 2019 | 4 |
| 2017 | 1 |
| 2015 | 1 |
No forecast is made for this condition: it averages 1.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Granulomatous Mastitis trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1/2 | 2 |
| Phase 4 | 3 |
| Not applicable | 4 |
| Observational | 8 |
How many Granulomatous Mastitis trials are recruiting? (6)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 3 |
| Recruiting | 3 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 1 |
| Completed | 6 |
Showing 5 of 6 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Granulomatous Mastitis trials? (3)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Istanbul Training and Research Hospital | 2 |
| European Breast Cancer Research Association of Surgical Trialists | 1 |
| Gaziosmanpasa Research and Education Hospital | 1 |
Which drugs are being tested for Granulomatous Mastitis? (4)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Locoid | 1 |
| Omeprazole 20 mg | 1 |
| Folic (or folinic) acid | 1 |
| PREDNISOLONE | 1 |
Interventions as named in the registry (9)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Hydrocortisone Butyrate 0.1% Cream | 1 |
| Steroid | 1 |
| Corticosteroid Therapy | 1 |
| tocilizumab SC | 1 |
| HD- Methotrexate (MTX) | 1 |
Showing 5 of 9 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Granulomatous Mastitis? (26)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Ductal lavage followed by observation versus oral corticosteroids in idiopathic granulomatous mastitis: A randomized trial. | Nature communications | 2024 | Yes |
| Idiopathic Granulomatous Mastitis: Six years of experience and the current evidence in literature. | Sultan Qaboos University medical journal | 2023 | Yes |
| Local Steroid Treatment: An Effective Procedure for Idiopathic Granulomatous Mastitis, Including Complicated Cases. | Journal of investigative surgery : the official journal of the Academy of Surgical Research | 2022 | Yes |
| Management of granulomatous lobular mastitis: an international multidisciplinary consensus (2021 edition). | Military Medical Research | 2022 | Yes |
| Corticosteroids in idiopathic granulomatous mastitis: a systematic review and meta-analysis. | Surgery today | 2021 | Yes |
Showing 5 of 26 publications.
Prevalence (3)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Granulomatous mastitis | Point prevalence | 1-9 / 100 000 | Worldwide | Not stated | Unspecified |
| Granulomatous mastitis | Point prevalence | 1-9 / 100 000 | Worldwide | Not stated | Exact |
| Granulomatous mastitis | Point prevalence | 1-9 / 100 000 | Worldwide | Not stated | Exact |
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Granulomatous mastitis | 64722 | Exact | Orphadata Science knowledge files, Product 1 |
| Granulomatous mastitis | 64722 | Exact | Orphanet Rare Disease Ontology (ORDO) |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials and sub-conditions in mesh.